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Abstract
Background: Stroke is a serious complication of sickle cell disease (SCD) in children. Transcranic
Doppler (TCD) is a well-established predictor of future cerebrovascular symptoms: a blood flow velocity
>200 cm/sec in the Middle Cerebral Artery (MCA) correlates with a high risk of stroke in cohorts of
African-american HbS/HbS patients. In North-East Italy the recent increase in SCD patients is mainly due
to immigration from Africa. A comprehensive care program for children with SCD was established in our
Center since 2004, but a wide and routine screening for Primary stroke prevention needs to be developed.
Methods: In order to verify the feasibility of TCD and Transcranial color coded Sonography (TCCS)
screening in our setting and the applicability of international reference values of blood velocities to our
population of African immigrants with HbS/HbS SCD, we performed TCD and TCCD in 12 HbS/HbS
African children and two groups of age-matched controls of Caucasian and African origin respectively.
TCD and TCCS were performed on the same day of the scheduled routine hematologic visit after parental
education.
Results: All parents accepted to perform the sonography to their children. TCD and TCCD were
performed in all patients and an adequate temporal window could be obtained in all of them. Pulsatility
index and depth values in both the MCA and the Basilar Artery (BA) were similar at TCD and TCCS
evaluation in the three groups while time-average maximum velocities (TAMM), peak systolic velocity and
diastolic velocity in the MCA and BA were higher in the patients' group on both TCD and TCCS
evaluation. African and Caucasian healthy controls had similar lower values.
Conclusion: Our preliminary data set the base to further evaluate the implementation of a primary stroke
prevention program in our setting of HbS/HbS African immigrants and HbS/beta thalassemia Italians.
Parental education-preferably in the native language- on stroke risk and prevention in SCD increases
compliance and should be a necessary part of the program. Ethnic background does not seem to influence
TCD velocity and internationally accepted reference values already validated in African-American SCD
pediatric patients can be used, but long prospective trials are needed to verify their efficacy in defining
stroke risk in our setting.
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Background
Inherited hemoglobin disorders are an increasing global
health problem[1]. Italy is a natural reservoir of Sickle Cell
Disease (SCD) due to the high frequency of the S gene in
the Sicilian population (2–13%) [2] and to the high fre-
quency of beta thalassemia mutations in the Italian pop-
ulation (6–11%)[3]. HbS/HbS and HbS/βthalassemia
forms of SCD are therefore already present in Italy. Glo-
balization, with its population movements, brought to
the Northern Regions of Italy immigrants from areas
where other SCD variants are even more frequent (HbS/
HbS with different aplotypes or HbS/HbC) [1]. This led to
an increase of SCD patients, mainly African immigrants
[4] and raises the need to organize a network of care tai-
lored to the specific needs of our population of SCD
patients.
In fact, SCD shows extreme phenotypic variability among
individuals and among populations [1,2,5]. Both envi-
ronmental and genetic factors are likely to contribute to
most manifestations of HbS/HbS SCD disease that devel-
ops with different patterns in various ethnic groups and
individuals [5,6].
Stroke is a frequent complication of SCD. Approximately
10% of African-american patients have a clinical stroke
before 20 years of age [7] and another 22% have a silent
infarction on magnetic resonance imaging [8]. Stroke has
also been described in Mediterranean [6,9] and African
SCD patients [10-13] even though with lesser frequencies
(4.1% and 6.7% respectively).
Screening programs for stroke prevention in SCD children
have been implemented in the United States and in some
European countries where comprehensive services for
SCD patients are part of routine care [14-17] using Tran-
scranial Doppler (TCD). TCD can measure flow velocities
in the large intracranial arteries. The narrowing of these
arteries, which leads to cerebral infarction is characterized
by an increased velocity of flow. Long term prospective
studies have demonstrated the validity of TCD in identify-
ing children at risk of stroke due to increased cerebral
velocities[14]. These studies have also demonstrated that
prevention of the first stroke (primary prevention) can be
done with success with chronic transfusion in children at
risk for stroke according to abnormal blood flow TCD
velocities [15]. Although TCD cannot predict all strokes,
TCD and TCCS offer an opportunity to apply an effective
therapy (chronic transfusion) for patients in the risk
group [7,14,15].
TCD/TCCS Reference peak-flow velocity values defining
normal, conditional and at-risk patients (TAMM <170,
170–200, >200 cm/sec respectively) have been defined
through long-term prospective studies performed in Afri-
can-american patients with HbS/HbS or HbS/HbC disease
in the United States [7,14]. The same reference values
have also been used in Caucasian patients with HbS/βtha-
lassemia in Greece demonstrating an equal validity in pre-
dicting stroke[16]. But TCD or TCCS studies are not yet
performed in African countries and normal reference val-
ues or baseline data for African SCD patients or for
healthy Africans are therefore not yet available. The stroke
predictive power of TCD in African populations has there-
fore not been demonstrated.
In Italy a National Comprehensive Program for the care
and treatment for SCD is still missing and a routine
screening with TCD able to reach the majority of SCD
pediatric patients has still to be implemented. Italian
national reported data on TCD values are mainly from
Caucasian adult patients during acute stroke or from the
healthy adult female population [18,19]. A survey on the
healthy pediatric Italian population or the healthy first
generation of African immigrant children is missing.
One of the major concerns in TCD/TCCS screening pro-
grams in US and UK is the limited access that patients and
family have to routine TCD/TCCS exams. Several studies
have in fact outlined that even though TCD screening is
included in the American National Institute of Health
(NIH) guidelines [20] and British National Health System
(NHS) [21] guidelines of standard health maintenance for
SCD children, wide application of this procedure is
uncommon [21-24]. Overburdening children and fami-
lies with too many appointments and not including TCD/
TCCS in routine hematological visits are one of the causa-
tive factors of non adherence to TCD screening. Others
include poor understanding of TCD/TCCS usefulness to
prevent serious complications by the parents. These issues
are of particular concern when dealing with a population
of first-generation immigrants – as the one that mainly
constitutes the group of SCD pediatric patients in Italy-
and must be taken into account in the design of a primary
stroke prevention program in our setting.
In order to set up a Primary Stroke Prevention Program in
our region, we performed a pilot study to determine the
feasibility of TCD and TCCS in a group of African children
with SCD routinely followed at the Clinic of Pediatric
Hematology-Oncology of the University of Padova.
With the objective of increasing acceptance of TCD/TCCS
screening and compliance to follow-up we stressed the
educational part, performed in different languages
With the aim of verifying if internationally accepted refer-
ence values could also apply to our population and could
be used as reference screening values, we compared cere-
bral velocities, pulsatility indexes and depth of theItalian Journal of Pediatrics 2009, 35:15 http://www.ijponline.net/content/35/1/15
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patient's group to those of two groups of healthy age-
matched controls of Caucasian and African origin respec-
tively.
Materials and methods
Patients enrolment
TCD and TCCS screening were proposed to the parents of
African children with SCD routinely followed at the Clinic
of Pediatric Hematology-Oncology of the University of
Padova. After explaining the neurological complications
of SCD and the possibility to identify children at risk of
stroke with TCD/TCCS, the opportunity to perform the
screening during one of the scheduled routine hematol-
ogy visits was offered. To be sure of proper understanding,
explanations to parents were performed not only in Ital-
ian, but also in English or French, according to the need.
Age-matched controls were recruited among healthy Cau-
casian and African children known by the physicians.
TCD-TCCS
TCD and TCCS were performed on the same day of a
scheduled hematology visit and in the same hospital com-
plex were the Pediatric Hematology-Oncology Clinic is
located.
TCD and TCCS were performed using a 2 MHz pulsed
Doppler ultrasonograph (EME TCD 2000/S) and a ATL
HDI 3000/S Echo Doppler system respectively. Patients
were not sedated during the examination.
We have measured peak systolic blood flow velocities
(PSV), end diastolic blood flow velocities (EDV), time-
averaged mean velocity of maximum blood flow (TAMM)
and mean blood flow velocities (MV), at the level of the
Basilar Artery (BA) and of the Middle Cerebral Artery
(MCA) on both sides of the brain.
We used the Stroke Prevention Trial in Sickle Cell Anemia
Study (STOP) criteria [7,14,15], which are based on the
intracranial velocities (TAMM) measured in the MCAs, by
the TCD method, to assign stroke risk as low (TAMM <
170 cm/sec), conditional (TAMM ≥ 170 – 199 cm/sec), or
high (TAMM ≥ 200 cm/sec).
In our study we decided to assess also the blood flow
velocities of the BA as we wanted to explore the intracra-
nial hemodynamics of the Vertebro Basilar circulation in
SCD (an arterial territory not evaluated in the STOP Trial).
The intracranial blood flow velocities can have a wide var-
iations in different normal subjects depending on several
factors (age, angle correction, diameter of the vessel).
Statistical Analyses
The Kolmogorov-Smirnov test was used to preliminary
check the normality of the variables. The One-Way Analy-
sis of Variance was then performed. The significance level
was set at p < 0.05.
Results
Thirty-six children were enrolled: group A with 12 SCD
HbS/HbS African patients, Group B with 12 healthy Afri-
can age-matched controls, Group C with 12 healthy Cau-
casian age-matched controls. Each group had 8 Females
and 4 Males. Mean age was 4.51 ± 2.87 years (range: 1.06–
9.86), 5.75 ± 3.38 (range:1.21–12.55), 6.84 ± 3.6 (range:
1.41–12.07) for GROUP A, B and C respectively with no
significantly statistical difference (p = 0.55).
TCD and TCCS were performed in all patients and an ade-
quate temporal window could be obtained in all of them.
Pulsatility index and depth values in both the MCA and
the BA (Fig 1, 2) were similar at TCD and TCCS evaluation
in the three groups. TAMM, PSV and EDV in the MCA and
BA (Fig. 3, 4) were significantly higher in group A patients
on both TCD and TCCS evaluation (p = 0.0001 and p =
0286, respectively). No difference was observed between
the right and left side. TCCS values were slightly higher
that TCD values, with no statistical difference.
Three GROUP A patients had conditional velocities, the
remaining being normal. In our population none had
abnormal velocity, even though the overall mean veloci-
ties were higher than control ones.
Discussion
Evaluating immigrant children with SCD using TCD and
TCCS for primary stroke prevention in our setting is feasi-
Middle Cerebral Artery: Mean of Depth (circle) and Pulsatil- ity index (square) in TCD (narrow line) and TCCS (thick  line) in the three groups of patients A, B, C Figure 1
Middle Cerebral Artery: Mean of Depth (circle) and 
Pulsatility index (square) in TCD (narrow line) and 
TCCS (thick line) in the three groups of patients A, 
B, C.Italian Journal of Pediatrics 2009, 35:15 http://www.ijponline.net/content/35/1/15
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ble, even if neurosonology examinations are not yet rou-
tinely performed for children or adolescents. All parents
accepted to perform TCD and TCCS and both exams were
feasible in all children. Performing TCD and TCCS during
a routine visit at the Hematology Clinic without over
burning families with other appointments, might have
helped in assuring a positive answer and in assuring com-
pliance for successive controls as happened in other coun-
tries [21-24]. The education of parents on neurological
complications of SCD and the benefits of screening, as
well as the reassurance on the lack of risk of the TCD pro-
cedure, emerges as a fundamental component of a suc-
cessful stroke prevention program in our setting.
Performing education in a language that parents can
understand, feeling free to expose doubts and ask ques-
tions without the linguistic barriers that immigrant par-
ents and patients generally experience, is surely a simple
way to increase adherence and participation.
Greater variability of TCCS compared to TCD in our pop-
ulation correlates with previous reports [25]. TCD was
easily performed in pediatric patients than TCCS due to
the less time needed to perform the exam.
Extreme phenotypic variability is a landmark of SCD
[1,6]. Various reports describe different clinical patterns in
different populations, according to haplotype of the
βglobin genes and related genes [26]. Various reports indi-
cate also cerebrovascular complications of SCD as hap-
pening with different prevalence in different populations.
Even though excess stroke risk exists in blacks [27,28], it
has been postulated that stroke occurs with less frequency
in African SCD children compared to Caucasians or Afri-
can-americans [10,11,29], questioning the need to per-
form regular screening in these populations. A 11%
prevalence of stroke has been observed in the American
Cooperative Study of Sickle Cell Disease [7,8] while a
6.7% prevalence of clinically evident stroke has been
reported in first generation SCD African immigrants living
in France [30]. In the French cohort of homozygous HbS/
HbS african children, abnormal TCD has been reported in
9.6% of cases [30,31], while abnormal TCD was present
in 9.5% to 12% of the American cohorts [14,15].
Basilar Artery: Mean of Depth (circle) and Pulsatility index  (square) in TCD (narrow line) and TCCS (thick line) in the  three groups of patients A, B, C Figure 2
Basilar Artery: Mean of Depth (circle) and Pulsatility 
index (square) in TCD (narrow line) and TCCS (thick 
line) in the three groups of patients A, B, C.
Middle Cerebral Artery: Mean of PSV (circle), TAMM  (square) EDV (triangle) in TCD (narrow line) e TCCS (thick  line) in the three groups of patients A, B, C Figure 3
Middle Cerebral Artery: Mean of PSV (circle), TAMM 
(square) EDV (triangle) in TCD (narrow line) e 
TCCS (thick line) in the three groups of patients A, 
B, C.
Basilar Artery: Mean of PSV (circle), TAMM (square) EDV  (triangle) in TCD (narrow line) e TCCS (thick line) in the  three groups of patients A, B, C Figure 4
Basilar Artery: Mean of PSV (circle), TAMM (square) 
EDV (triangle) in TCD (narrow line) e TCCS (thick 
line) in the three groups of patients A, B, C.Italian Journal of Pediatrics 2009, 35:15 http://www.ijponline.net/content/35/1/15
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In our study, Caucasian healthy and African healthy chil-
dren had similar low values of all parameters measured on
TCD and TCCS. SCD African patients had higher mean
values of velocities, but pulsatility and depth were similar
to healthy controls, both white and black. These data sug-
gest that ethnic background does not influence baseline
normal values of pulsatility, depth and velocities parame-
ters and that SCD is the only factor influencing and deter-
mining velocities increase. Pulsatility index, indicating
vascular resistance, does not seem to be influenced by
SCD being the same in the three groups of children.
In our group of patients, at the time of the analysis, none
presented abnormal velocities even thought mean veloci-
ties were higher that in controls. Three children (25%),
however, had conditional values. The lower Mean age in
our group compared to the one of the French cohort
(mean 10.1 ± 5.8 years and median 9.3 years) [30,31]
could partially be taken as an explanation of this data.
Longer follow up and a larger population is needed to pre-
cisely define the risk of stoke and the percentage of abnor-
mal TCD in African children with SCD. The three children
that had conditional velocities (170–200 cm/sec) at ini-
tial evaluation, developed abnormal high velocities (>200
cm/sec) after six months and had to be placed on a
chronic transfusion program; one child developed
ischemic stroke while waiting for the first transfusion.
These preliminary data suggest that a primary stroke pre-
vention program for our population is necessary and set
the base to further evaluate the implementation of such a
program in our setting of HbS/HbS African immigrants
and HbS/beta thalassemia Italians.
With appropriate training and coordination between
Pediatric Sickle Cell Groups and Neurosonology Services,
the costs of the screening could be very limited. The Adult
Neurosonology Services that are already developed across
Italy for the evaluation of Adult Stroke could use the
equipment and the personnel already available in the
Adult Stroke Team to perform TCD screening in pediatric
sickle cell patients. For the present being, the small
number of pediatric sickle cell patients is not likely to over
burn the neurosonology services and to raise the need of
adjunctive pediatric neurosonology services
Investigating multiple cerebral vascular districts, besides
the MCA, could aid in defining the ones that can be easily
monitored and that could better predict future stroke.
Conclusion
Evaluation of blood flow in the MCAs and in the BA
through two different intracranial ultrasonographic tech-
niques is feasible in pediatric SCD African immigrants. A
routine primary stroke prevention program should be
implemented as part of comprehensive standard health
evaluation for SCD children in our setting and parent edu-
cation-possibly in the native language-should be a neces-
sary part of the program.
The definitive validity in our setting of the internationally
accepted reference cut-off values already in use in other
Caucasian and African-american SCD pediatric patients
should be confirmed in a wide prospective study.
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